These results demonstrate contrasting activatory and inhibitory roles of LYL1 in PER-117 and JURKAT, respectively, betraying further differences in NKX3-1 regulation in these T-ALL subtypes. The gene discussed is NKX3-1; the disease is acute lymphoblastic leukemia.